Prudential Financial’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,682
| Closed | -$231K | – | 2737 |
|
|
2021
Q3 | $231K | Sell |
1,682
-98
| -6% | -$12.8K | ﹤0.01% | 2430 |
|
|
2021
Q2 | $223K | Hold |
1,780
| – | – | ﹤0.01% | 2421 |
|
|
2021
Q1 | $242K | Sell |
1,780
-688
| -28% | -$88.9K | ﹤0.01% | 2345 |
|
|
2020
Q4 | $315K | Sell |
2,468
-16
| -0.6% | -$1.88K | ﹤0.01% | 2231 |
|
|
2020
Q3 | $280K | Sell |
2,484
-36,263
| -94% | -$3.61M | ﹤0.01% | 2186 |
|
|
2020
Q2 | $3.69M | Sell |
38,747
-52,148
| -57% | -$5.03M | 0.01% | 1081 |
|
|
2020
Q1 | $8.17M | Buy |
90,895
+86,509
| +1,972% | +$6.72M | 0.02% | 714 |
|
|
2019
Q4 | $232K | Buy |
+4,386
| New | +$200K | ﹤0.01% | 2292 |
|
|
2019
Q2 | – | Sell |
-4,733
| Closed | -$221K | – | 2510 |
|
|
2019
Q1 | $221K | Buy |
+4,733
| New | +$208K | ﹤0.01% | 2295 |
|
|
2018
Q4 | – | Sell |
-14,379
| Closed | -$823K | – | 2474 |
|
|
2018
Q3 | $823K | Sell |
14,379
-31,894
| -69% | -$1.57M | ﹤0.01% | 1926 |
|
|
2018
Q2 | $2.25M | Sell |
46,273
-64,820
| -58% | -$2.36M | ﹤0.01% | 1588 |
|
|
2018
Q1 | $4.34M | Sell |
111,093
-49,017
| -31% | -$2.08M | 0.01% | 1229 |
|
|
2017
Q4 | $6.92M | Buy |
160,110
+79,100
| +98% | +$2.97M | 0.01% | 1023 |
|
|
2017
Q3 | $3.02M | Buy |
+81,010
| New | +$2.81M | ﹤0.01% | 1377 |
|
|
2017
Q1 | – | Sell |
-73,730
| Closed | -$1.88M | – | 2388 |
|
|
2016
Q4 | $1.88M | Sell |
73,730
-100
| -0.1% | -$3.17K | ﹤0.01% | 1573 |
|
|
2016
Q3 | $2.67M | Sell |
73,830
-7,670
| -9% | -$254K | ﹤0.01% | 1367 |
|
|
2016
Q2 | $2.77M | Sell |
81,500
-8,700
| -10% | -$283K | ﹤0.01% | 1400 |
|
|
2016
Q1 | $2.38M | Buy |
90,200
+21,500
| +31% | +$625K | ﹤0.01% | 1475 |
|
|
2015
Q4 | $3.35M | Buy |
+68,700
| New | +$2.47M | 0.01% | 1258 |
|
Prudential Financial's XLRN Position: Q4 2021 in Review
Prudential Financial sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,682 shares — an estimated $231K sold.
Prudential Financial first reported a position in XLRN in Q4 2015 and held it in 19 quarters. The position peaked at $8.17M in Q1 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Prudential Financial reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Prudential Financial sold 1,682 Acceleron Pharma shares in Q4 2021, an estimated $231K.
- Prudential Financial first reported a position in Acceleron Pharma in Q4 2015 and held it in 19 quarters.
- Prudential Financial's Acceleron Pharma position peaked at $8.17M in Q1 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Prudential Financial's 13F filing for Q4 2021, filed 14 Feb 2022.